PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹17,567 Cr | ₹15,369 Cr | ₹14,925 Cr | ₹14,437 Cr | ₹12,717 Cr |
What is the latest Total Liabilities ratio of PIRAMAL PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹17,567 Cr |
| Mar2025 | ₹15,369 Cr |
| Mar2024 | ₹14,925 Cr |
| Mar2023 | ₹14,437 Cr |
| Mar2022 | ₹12,717 Cr |
How is Total Liabilities of PIRAMAL PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹17,567 Cr | 14.30 | |
| Mar2025 | ₹15,369 Cr | 2.97 | |
| Mar2024 | ₹14,925 Cr | 3.39 | |
| Mar2023 | ₹14,437 Cr | 13.52 | |
| Mar2022 | ₹12,717 Cr | - | |
Compare Total Liabilities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹28,283.5 Cr | 1.5% | 23.7% | 13% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,155.0 Cr | -0.3% | -0.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 3.1% | 16.7% | 39.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,479.0 Cr | -1.5% | -2.8% | 38.7% | Stock Analytics | |
| CIPLA | ₹118,027.0 Cr | -0.8% | 1.6% | -1.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,662.0 Cr | 2.9% | -1.9% | 0.2% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 1.5% |
23.7% |
13% |
| SENSEX | -1.1% |
1.3% |
-3.3% |
You may also like the below Video Courses